AstraZeneca Pharma shares rose after the company received regulatory approval to expand the use of its cancer drug Imfinzi ...

FRANKFURT: European shares ended slightly lower on Tuesday, with industrials and banks the biggest drags as investors weighed ...

EUROPEAN shares ended slightly lower on Tuesday, with industrials and banks the biggest drags as investors weighed ...

European shares fell on Tuesday on the back of poor performances from the banking and defence sectors, as uncertainty ...

By Sukriti Gupta, Sanchayaita Roy and Shashwat Chauhan (Reuters) -European shares ended slightly lower on Tuesday, with industrials and banks the biggest drags as investors weighed uncertainty over U.

(Reuters) -AstraZeneca chief executive Pascal Soriot is considering moving the company's stock market listing to the United ...

From drug trials to mechanistic insights, EULAR 2025 delivers wide-ranging data that may inform tomorrow’s standards in ...

Hydroxychloroquine is tied to reduced preeclampsia risk but not preterm birth risk in pregnant patients with lupus in a ...

Europe's military capabilities remain heavily reliant on the US, while both Russia and China have substantially advanced ...

A sign of the CDC is seen on a podium during the meeting of the members of the Advisory Committee on Immunization Practices, ...

"Rising liver disease cases and biotech innovations are fueling demand for advanced therapies, with personalized medicine and fibrosis-targeting treatments shaping the global market landscape." BOSTON ...